Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl)Cyclohexanecarboxamide (cas 1122-56-1)s as Rho kinase inhibitors and neurite outgrowth promoters
-
Add time:09/27/2019 Source:sciencedirect.com
The influence of stereochemistry and alkyl side chain length on the bioactivity of the Rho kinase inhibitor Y-27632 [(+)-1, R = Me] was examined by the synthesis of (+)- and (−)-1, and two alkyl chain analogs (+)- and (−)-2 (R = n-propyl) and (−)-3 (R = n-octyl) as well as their evaluation in enzymatic and neurite outgrowth assays.
We also recommend Trading Suppliers and Manufacturers of Cyclohexanecarboxamide (cas 1122-56-1). Pls Click Website Link as below: cas 1122-56-1 suppliers
Prev:Original articleDesign, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)Cyclohexanecarboxamide (cas 1122-56-1) (WAY-100635) for the 5-HT1A receptor
Next:XeO3 adducts of pyridine, 4-Dimethylaminopyridine (cas 1122-58-3), and their pyridinium salts) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleDesign, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)Cyclohexanecarboxamide (cas 1122-56-1) (WAY-100635) for the 5-HT1A receptor09/26/2019
- Enthalpies of dilution of benzamide, Cyclohexanecarboxamide (cas 1122-56-1), and N-acetyl-N′-methyl-l-cyclohexylalaninamide dissolved in N,N-dimethylformamide at 298.15 K09/25/2019
- β-Substituted Cyclohexanecarboxamide (cas 1122-56-1) cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core09/24/2019


